About the journal
Frontiers in Oncology is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,150 CHF. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2234-943X
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,150 CHF
- Articles in DOAJ
- 38500
- Declared review time
- 14 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/oncology/
Index listings
- DOAJ · 2012-08-14
- PUBMED · 2011-07-28
- Indexing
- DOAJ · PUBMED
- APC
- 3,150 CHF
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
38500
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
37245
Last recorded publication year
2026
h-index
205
i10-index
16086
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2012-08-14
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101568867
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- Glioma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Glioma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Head and Neck Cancer Studies
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Head and Neck Cancer Studies
- Breast Cancer Treatment Studies
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Inflammatory Biomarkers in Disease Prognosis
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Cancer Cells and Metastasis
- Gastric Cancer Management and Outcomes
- Cancer Cells and Metastasis
- Endometrial and Cervical Cancer Treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Epigenetics and DNA Methylation
- Endometrial and Cervical Cancer Treatments
- Esophageal Cancer Research and Treatment
- Epigenetics and DNA Methylation
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal Cancer Research and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Keywords (DOAJ)
- cancer research
- clinical oncology
- cancer genetics
- molecular targets
- surgical oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ